Letters to the Editor
Clinical improvement following interferon-α alone as an initial treatment in CIDP
Hirotsugu Harada MD,
Hirotsugu Harada MD
Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this author Norio Ohkoshi MD,
Norio Ohkoshi MD
Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this author Youshi Fujita MD,
Youshi Fujita MD
Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this author Akira Tamaoka MD,
Akira Tamaoka MD
Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this author Shin'ichi Shoji MD,
Shin'ichi Shoji MD
Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this author
Hirotsugu Harada MD,
Hirotsugu Harada MD
Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this author Norio Ohkoshi MD,
Norio Ohkoshi MD
Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this author Youshi Fujita MD,
Youshi Fujita MD
Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this author Akira Tamaoka MD,
Akira Tamaoka MD
Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this author Shin'ichi Shoji MD,
Shin'ichi Shoji MD
Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
Search for more papers by this author
First published: 18 January 2000
No abstract is available for this article.
REFERENCES
- 1Choudhary PP, Thompson N, Hughes RAC. Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 1995; 242: 252–253.
- 2Gorson KC, Ropper AH, Clark BD, Dew RB III, Simovic D, Allam G. Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-α 2a. Neurology 1998; 50: 84–87.
- 3Noronha A, Toscas A, Jensen MA. Interferon-β decreases T cell activation and interferon-γ production in multiple sclerosis. J Neuroimmunol 1993; 46: 145–154.
- 4Pollard JD. Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 1986; 13: 123–134.
- 5Sabatelli M, Mignogna T, Lippi G, Milone M, Di Lazzaro V, Tonali P, Bertini E. Interferon-α may benefit steorid unresponsive chronic inflammatory neuropathy. J Neurol Neurosurg Psychiatry 1995; 58: 638–639.
